Immature T-cell Clustering and Efficient Differentiation Require the Polarity Protein Scribble
Overview
Authors
Affiliations
T-cell polarization is required for cell migration and cell-cell interactions, cellular behaviors crucial for lymphocyte differentiation. Despite expression of the epithelial polarity network in T cells, neither its contribution to thymocyte polarity nor its requirement during development is known. We report here that depletion of the polarity protein Scribble in hematopoietic progenitor cells results in inefficient T-cell development characterized by a partial developmental block during the early double-negative (DN) stage of differentiation. Scribble-depleted hematopoietic progenitor cells exhibit a delayed transition into late CD44(lo/-)CD25(+) DN3 cells, evidenced by the accumulation of early CD44(int)CD25(+) DN3 cells. As a consequence, a limited cellular expansion and a reduced frequency of intracellular T-cell receptor β-positive DN3 cells are observed among Scribble-deficient differentiating T cells. Moreover, whereas purified Scribble-depleted DN2 and DN3 cells do not exhibit compromised spontaneous motility, T-cell clustering and prolonged homotypic interactions among such cells are reduced. This deficiency correlates with a lack of polarization of the integrin LFA-1 during T-cell migration or on the initiation of T-cell-T-cell interactions. Scribble is therefore a critical contributor to the clustering of immature T cells, an event shown here to be necessary for efficient developmental progression.
Charnley M, Allam A, Newton L, Humbert P, Russell S Sci Adv. 2023; 9(3):eade5348.
PMID: 36652509 PMC: 11811980. DOI: 10.1126/sciadv.ade5348.
Javorsky A, Maddumage J, Mackie E, Soares da Costa T, Humbert P, Kvansakul M FEBS J. 2022; 290(4):974-987.
PMID: 36029163 PMC: 10952772. DOI: 10.1111/febs.16607.
The Scribble Complex PDZ Proteins in Immune Cell Polarities.
Barreda D, Gutierrez-Gonzalez L, Martinez-Cordero E, Cabello-Gutierrez C, Chacon-Salinas R, Santos-Mendoza T J Immunol Res. 2020; 2020:5649790.
PMID: 32411799 PMC: 7210543. DOI: 10.1155/2020/5649790.
Heidel F, Ellis S Oncotarget. 2018; 9(78):34642-34643.
PMID: 30410664 PMC: 6205173. DOI: 10.18632/oncotarget.26132.
Dash B, Schnoder T, Kathner C, Mohr J, Weinert S, Herzog C J Cancer Res Clin Oncol. 2018; 144(10):1933-1944.
PMID: 30083817 DOI: 10.1007/s00432-018-2724-3.